PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc., (NASDAQ: ADXS), a leader in developing the next generation of cancer immunotherapies, announced that ADXS-cHER2, its proprietary immunotherapy for the treatment of breast cancer and canine osteosarcoma, was featured on ABC News in an article titled “Bone Cancer Vaccine for Dogs Shows Promise for Breast Cancer”.
Help employers find you! Check out all the jobs and post your resume.
